Atherosclerosis is a chronic inflammatory disease and represents the major cause of cardiovascular morbidity and mortality. A critical regulator of inflammatory processes represents the mitogen-activated protein kinase-activated protein kinase-2 (MK2). Therefore, we investigated the functional role of MK2 in atherogenesis in hypercholesterolemic mice as well as potentially underlying mechanisms in vivo and in vitro. Activation of MK2 (phospho-MK2) was predominantly detected in the endothelium and macrophage-rich plaque areas within aortas of hypercholesterolemic LDL receptor-deficient mice (ldlr Ϫ/Ϫ ). Systemic MK2 deficiency of hypercholesterolemic ldlr Ϫ/Ϫ mice (ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ ) significantly decreased the accumulation of lipids and macrophages in the aorta after feeding an atherogenic diet for 8 and 16 weeks despite a significant increase in proatherogenic plasma lipoproteins compared with ldlr Ϫ/Ϫ mice. Deficiency of MK2 significantly decreased oxLDL-induced foam cell formation in vitro, diet-induced foam cell formation in vivo, and expression of scavenger receptor A in primary macrophages. In addition, systemic MK2 deficiency of hypercholesterolemic ldlr Ϫ/Ϫ mice significantly decreased the aortic expression of the adhesion molecule VCAM-1 and the chemokine MCP-1, key mediators of macrophage recruitment into the vessel wall. Furthermore, silencing of MK2 in endothelial cells by siRNA reduced the IL-1␤-induced expression of VCAM-1 and MCP-1. MK2 critically promotes atherogenesis by fostering foam cell formation and recruitment of monocytes/macrophages into the vessel wall. Therefore, MK2 might represent an attractive novel target for the treatment of atherosclerotic cardiovascular disease. (Circ Res.
A therosclerosis is a chronic inflammatory disease. [1] [2] [3] [4] [5] This process is initiated by trapping and modification of apo-B-containing lipoproteins into the vessel wall resulting in increased expression of adhesion molecules (eg, VCAM-1) and chemokines (eg, MCP-1) by the endothelium. The latter is followed by recruitment of monocytes into the vessel wall, where these cells differentiate into macrophages. Inflammatory macrophages produce a plethora of inflammatory mediators (eg, chemokines, cytokines) sustaining and promoting the inflammatory process. Furthermore, macrophages develop into foam cells by unrestricted uptake of modified lipoproteins (eg, oxLDL) through scavenger receptors (SR-A, CD36). [1] [2] [3] [4] [5] [6] [7] [8] The mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MAPKAPK-2, MK2) is a direct substrate of the stress activated MAPK p38␣ and ␤. 9 Recent studies performed with MK2-deficient cells in vitro demonstrate a central role of MK2 in the production of proinflammatory mediators such as TNF␣, IL-1␤, MIP-1␣, IL-8, IL-6, and INF␥. 10 -13 One important mechanism MK2 uses to increase the expression of proinflammatory mediators is the modulation of mRNA-stability by targeting AU-rich elements located in the 3Ј-untranslated region of the mRNA of proinflammatory mediators (e. g. TNF␣, IL-6) via phosphorylation of RNA-stability regulating proteins (eg, tristetraprolin). 11, 12, 14 Furthermore, MK2 possesses an important functional role in cell migration and chemotaxis by regulating actin remodeling and stress fiber formation via phosphorylation of Hsp27 and activation of the LIM-kinase-cofilin pathway. [15] [16] [17] Besides these in vitro data the important functional role of MK2 for inflammatory processes was most clearly revealed in MK2-deficient mice used in in vivo models of inflammatory diseases: MK2-deficient mice show a significantly reduced production of TNF␣ and IL-6 in response to LPS-challenge resulting in increased survival of LPS-induced septic shock and exhibit significantly reduced severity and incidence of joint inflammation in the collagen induced-arthritis model. 10, 18 As similar inflammatory pathways are also known to be involved in atherogenesis, MK2 appears to be an attractive and potentially selective target for the treatment of atherosclerosis. Importantly, MK2-deficient mice do not develop a lethal phenotype as well as signs of generalized inflammation per se. 10 Therefore, serious side effects should not be expected after blocking MK2 in vivo, which is in contrast to mice deficient for its upstream kinase p38␣/␤-MAPK, that develop an embryonically lethal phenotype. 19, 20 Therefore, the present study investigated the functional role of MK2 in atherogenesis in hypercholesterolemic mice in vivo as well as potentially underlying molecular mechanisms in MK2-deficient cells in vitro.
Materials and Methods

Treatment of Mice
LDLR-deficient mice (C57Bl/6, The Jackson Laboratories, Bar Harbor, Me) and MK2-deficient mice (C57Bl/6, backcrossed Ͼ10 generations) 10 were crossbred to generate ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ compound mutant mice. The genotype of each mouse was verified by PCR on genomic DNA (tail tip digest) using the following primers: LDLR: 5Ј-ACC CCA AGA CGT GCT CCC AGG ATG A -3Ј (sense), 5Ј -CGC AGT GCT CCT CAT CTG ACT TGT -3Ј (antisense); MK2: 5Ј -CGT GGG GGT GGG GTG ACA TGC TGG TTG AC -3Ј (sense), 3Ј -GGT GTC ACC TTG ACA TCC CGG TGA G -3Ј (antisense); Neomycin-Cassette: 5Ј -TGC TCG CTC GAT GCG ATG TTT CGC -3Ј (sense). 8-to 10-week-old male ldlr Ϫ/Ϫ and ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ compound-mutant mice (each group nϭ8 to 10) consumed a high-cholesterol diet (product #D12108, Research Diets; 1.25% Cholesterol without added cholate) for 8 and 16 weeks. Subsequently, mice were euthanized and the aortas were removed and analyzed as described below. Aortic arches were frozen in OCT compound (Tissue-Tek) and the thoracic and abdominal parts of the aortas were fixed in 10% buffered formalin, as described previously. 21 All mice were housed under specific pathogen-free conditions and all procedures were approved by the Institutional Animal Care and Use Committee at Hannover Medical School and the Bezirksregierung Niedersachsen.
Immunohistochemistry/Immunofluorescence
Serial cryostat sections (6 m) of mouse aortic arches were fixed in acetone (Ϫ20°C, 5 minutes), air dried, and stained by the avidinbiotin-peroxidase method, as previously described. 21 Controls for specificity used staining with the respective nonimmune IgG subclass (Pharmingen, DAKO). For immunfluorescence serial cryosections (6 m) of mouse aortic arches were fixed in paraformaldehyde (4°C, 15 minutes) and permeabilized with 0.1% Triton X-100 for 5 minutes. Sections were incubated with primary antibodies overnight at 4°C followed by incubation with a fluorescence dyeconjugated secondary antibody (Molecular Probes/Invitrogen). Nuclei were stained with 4Ј-6-diamidino-2-phenyl indole-2HCl (DAPI, Santa Cruz Biotechnologies). Control stainings with the respective nonimmune IgG control demonstrated specificity of the antiphospho-MK2 signal (supplemental Figure I , available online at http://circres.ahajournals.org). Antibodies used were: anti-mouse MOMA-2 (Pharmingen), anti-VCAM-1 (Pharmingen), anti-ICAM-1 (Pharmingen), anti-phopho-MK2 (Cell Signaling Technologies), anti-vWF (DAKO).
Oil Red O Staining for Lipids
Deposition of lipids in en face preparations of the Aorta descendens (fixed with 10% formalin) and cryo-sections of the aortic arch was determined by oil red O staining as described previously. 21
Tissue Analysis
To quantify the extent and composition of the aortic lesions longitudinal sections of the aortic arch were analyzed microscopically in all mice, as described previously. 21 In the aortic arch, a 2-mm proximal segment of the inner curvature, starting at a perpendicular dropped from the left side of the left subclavian artery origin, was analyzed for the total wall area. The respective areas positively stained for lipids (oil red O), macrophages (MOMA-2), VCAM-1, and ICAM-1 were determined via computer-assisted image quantification ( For other materials and methods, please refer to the supplemental materials and methods section (available online at http://circres.ahajournals.org).
Results
Phosphorylated MK2 Is Localized to the Endothelium and Macrophage-Rich Plaque Areas Within Aortas of Hypercholesterolemic ldlr ؊/؊ Mice
The phosphorylation of MK2 by the p38-MAPK is essential for its activation. 22 Therefore, we investigated the localization of phosphorylated MK2 in atherosclerotic lesions by performing immunfluorescence-staining in sections of the aortic arch of hypercholesterolemic ldlr Ϫ/Ϫ mice using specific antibodies against phospho-MK2. Immunfluorescence staining revealed a strong signal of phopho-MK2 in macrophagerich areas of advanced atherosclerotic lesions ( Figure 1A and 1B). Furthermore, strong phospho-MK2 staining could be detected in the endothelial cell layer of early as well as advanced atherosclerotic lesions ( Figure 1B 
MK2 Deficiency Inhibits Atherosclerosis by Reducing Vascular Lipid Deposition and Macrophage Content in Hypercholesterolemic ldlr ؊/؊ Mice
The functional role of MK2 in atherosclerosis was investigated by comparing the development of atherosclerosis in MK2-deficient (ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ ) and not MK2-deficient (ldlr Ϫ/Ϫ ) hyperercholesterolemic LDL receptor-deficient mice. Atherosclerosis was markedly reduced in ldlr Ϫ/Ϫ / mk2 Ϫ/Ϫ mice compared with ldlr Ϫ/Ϫ mice after feeding an atherogenic diet for 8 or 16 weeks as indicated by a significantly reduced lipid-positive area (oil red O) in the aorta descendens (en face, Figure 2A and Table 1 ) and the aortic arch (longitudinal sections, Figure 2B and Table 1 ). In addition, ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice had a significantly decreased macrophage content (MOMA-2) in longitudinal sections of the aortic arch ( Figure 2C and Table 1 ). Strikingly, the reduced lipid deposition and macrophage content observed in the aortas of hypercholesterolemic ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice occurred despite significantly increased plasma levels of total cholesterol and non-HDL-cholesterol compared with ldlr Ϫ/Ϫ mice ( Table 2 and supplemental Figure II ).
MK2-Deficiency Reduces Macrophage Foam Cell Formation and Scavenger Receptor A Expression
One possibility to explain reduced atherosclerosis observed in ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice in the face of a proatherogenic lipid profile could be a functional role of MK2 in macrophage foam cell formation. Therefore, we investigated the oxLDLinduced formation of foam cells in murine peritoneal macrophages isolated from MK2-deficient mice (mk2 Ϫ/Ϫ ) or wildtype control mice (wt). Deficiency of MK2 in murine macrophages caused a significantly reduced formation of oil red O-positive foam cells ( Figure 3A and 3B, wt versus mk2 Ϫ/Ϫ : 64.14Ϯ2.09% versus 31.92Ϯ1.78%, PϽ0.05). This was furthermore supported by a significantly reduced uptake of Dil-labeled oxLDL by MK2-deficient macrophages compared with wild-type controls ( Figure 3D , relative Dil-oxLDL-uptake wt versus mk2 Ϫ/Ϫ : 1.00Ϯ0.03 versus 0.57Ϯ0.02, PϽ0.01). Additionally, we used an in vivo model of foam cell formation as described by Li et al 23 to verify a functional role of MK2 in foam cell formation in vivo. In line with the impact of MK2-deficiency on foam cell formation in vitro, MK2 deficiency caused a significant reduction of oil red O-positive foam cells in preparations of peritoneal macrophages isolated from hypercholesterolemic ldlr Ϫ/Ϫ mice fed an atherogenic diet for 10 weeks compared with wild-type controls ( Figure 3C , ldlr Ϫ/Ϫ versus ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ : 52.92Ϯ8.28% versus 20.44Ϯ3.09%, PϽ0.05). Furthermore, the functional role of MK2 in cholesterol efflux from foam cells was investigated in oxLDL-loaded peritoneal macrophages isolated from wild-type control or MK2-deficient mice. Cholesterol efflux assays revealed no significant difference in cholesterol efflux towards HDL between oxLDLloaded wild-type control and MK2-deficient macrophages (percentage of released 3 H-cholesterol to total 3 H-cholesterol: wt versus mk2 Ϫ/Ϫ : 4.43Ϯ0.52% versus 5.67Ϯ0.45%, PϾ0.05, nϭ3). As the impaired foam cell formation in MK2-deficient macrophages could be caused by reduced expression of oxLDL scavenging receptors (CD36, SR-A), we determined mRNA and protein expression of SR-A and CD36 by quantitative real-time PCR and Western blotting, respectively. Analysis of the expression of SR-A and CD36 revealed a markedly reduced mRNA and protein expression of the scavenger receptor SR-A in MK2-deficient macrophages compared with wild-type macrophages, whereas no difference in the protein expression levels for CD36 was detected between wild-type and MK2-deficient macrophages ( Figure  3E and 3F; relative mRNA expression wt versus mk2 Ϫ/Ϫ : SR-A 1.00Ϯ0.08 versus 0.31Ϯ0.11, PϽ0.001; CD36 1.00Ϯ0.13 versus 0.41Ϯ0.10, PϽ0.05).
MK2-Deficiency Decreases the Expression of VCAM-1 and MCP-1 in Aortas of Hypercholesterolemic Mice and Endothelial Cells
Based on the strong reduction of the macrophage content in atherosclerotic vessels of ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice, especially in investigated the vascular expression of E-selectin, VCAM-1, ICAM-1, and MCP-1 in sections of the aortic arch of these mice by immunhistochemistry using specific antibodies. Whereas specific staining could be obtained for VCAM-1 and ICAM-1, specific staining could not be obtained in aortic sections of hypercholesterolemic ldlr Ϫ/Ϫ mice using different antibodies available for MCP-1 and E-selectin. In line, a previous report demonstrated lack of detection of E-selectin expression by immunhistochemistry in atherosclerotic murine aortas, although E-selectin expression was detectable by RT-PCR. 24 Aortic arches of hypercholesterolemic ldlr Ϫ/Ϫ / mk2 Ϫ/Ϫ mice revealed a significant reduced area positively stained for VCAM-1 compared with aortic arches of hypercholesterolemic ldlr Ϫ/Ϫ mice, whereas the area positively stained for ICAM-1 was not significantly different between these genotypes ( Figure 4B , % positive stained area ldlr Ϫ/Ϫ 
Figure 3. MK2-deficiency in macrophages reduces foam cell formation in vitro and in vivo and expression of scavenger receptor A.
A through C, Cultured primary murine peritoneal macrophages were harvested from wt and mk2 Ϫ/Ϫ mice and incubated with oxLDL (25 g/mL, 4 hour, 37°C) or harvested from ldlr Ϫ/Ϫ and ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice after feeding an atherogenic diet (1.25% Cholesterol) for 10 weeks and foam cell formation in vitro (A) and in vivo (C), respectively, was analyzed after staining cellular lipids with oil red O. Quantitative analysis of lipid-positive cells given as percentage of the total number of analyzed cells is displayed as mean Ϯ SEM (A, C) and representative images of oxLDL-treated macrophages stained with oil red O are shown (B). nϭ3, *PϽ0.05 wt vs mk2 Ϫ/Ϫ and ldlr Ϫ/Ϫ versus ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ . D, Cultured primary murine peritoneal macrophages harvested from wild-type (wt) and mk2 Ϫ/Ϫ mice were incubated with Dil-oxLDL (10 g/mL, 4 hours, 37°C) and oxLDL-uptake was analyzed with a fluorescence-photometer at excitation/emission wavelength of 520/580 nm and normalized to total cellular protein content. OxLDL-uptake is displayed as meanϮSEM given relative to wild-type. nϭ4, #PϽ0.01 wt vs mk2 Ϫ/Ϫ . E and F, Primary murine peritoneal macrophages isolated from wt and mk2 Ϫ/Ϫ mice were cultured and used for isolation of total RNA or protein lysates. mRNA and protein expression of scavenger receptors (SR-A, CD36) and housekeeping genes (18S, GAPDH) were determined by quantitative RT-PCR (E) and Western blotting (F) using specific primers and antibodies for SR-A, CD36, 18S, and GAPDH. Relative gene expression of SR-A and CD36 as determined by qRT-PCR is displayed as meanϮSEM, nϭ4, *PϽ0.05, §PϽ0.001 (E). Representative Western blots (F) of 4 different preparations of peritoneal murine macrophages are shown.
versus ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ , VCAM-1: 8.76Ϯ1.63% versus 4.46Ϯ0.58%, PϽ0.05, ICAM-1: 7.24Ϯ0.49% versus 6.22Ϯ 0.53%, PϾ0.05.
In addition, we investigated, whether the endothelial protein expression of VCAM-1 and MCP-1 is decreased by inhibition of MK2 expression in vitro. Using siRNA, protein expression of MK2 in human endothelial cells (HUVECs) was substantially reduced as determined by Western blotting (Figure 5A ). In line, the IL-1␤-induced phosphorylation of Hsp27, a major downstream target of MK2, was markedly reduced after silencing the expression of MK2 in HUVECs ( Figure 5B ). After successful inhibition of the expression and function of MK2 in HUVECs, the IL-1␤-induced expression of VCAM-1 ( Figure 5C ) and MCP-1 ( Figure 5D , control-siRNA versus MK2-siRNA, IL-1␤: 108.09Ϯ6.56 versus 67.74Ϯ6.91 ng/mL, PϽ0.01) was markedly and significantly reduced in endothelial cells, demonstrating a functional role of MK2 for the expression of VCAM-1 and MCP-1 in endothelial cells. These results indicate that the reduced accumulation of macrophages in atherosclerotic vessels of MK2-deficient mice might be caused by reduced expression of endothelial VCAM-1 and MCP-1.
Discussion
MK2 is an important regulator of inflammatory processes. 15, 16 Because atherosclerosis is considered a chronic inflammatory disease, [1] [2] [3] [4] [5] we hypothesized that MK2 might also play a central role in atherogenesis. The present study provides evidence for a causal involvement of MK2 in atherosclerosis on different levels of the disease process, namely increased macrophage foam cell formation and increased expression of mediators that are crucial for the recruitment of monocytes/macrophages into the vascular wall.
Initially performed experiments detected phosphorylated MK2 (indicating the active form of the enzyme 22 ) within the endothelial cell layer as well as advanced macrophage-rich atherosclerotic lesions, however, not in the smooth muscle cell-rich media of hypercholesterolemic mice. These data pointed to a role of MK2 in atherosclerosis, a process primarily initiated in endothelial cells and monocytes/macrophages. To further elucidate the involvement of MK2 in atherogenesis, the impact of MK2 deficiency was investigated in hypercholesterolemic ldlr Ϫ/Ϫ mice. ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice fed an atherogenic diet developed-for yet unknown reasons-a significant increase in apoB-containing lipoproteins without changes in HDL-cholesterol compared with controls. Strikingly, despite this clearly proatherogenic lipid profile ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice had a substantial decrease in early (8 weeks) as well as late (16 weeks) aortic atherosclerosis. MK2 deficiency apparently had a dual effect causing a significant reduction (Ϸ50% to 70%) in aortic lipiddepositions as well as macrophage infiltration.
The substantial reduction of lipid depositions we observed in the aorta of hypercholesterolemic MK2-deficient miceespecially in advanced atherosclerotic disease (16 weeks atherogenic diet)-is most likely attributable to an impaired uptake of modified atherogenic lipoproteins 25, 26 by MK2deficient macrophages in vivo based on our data: MK2 deficiency reduced oxLDL-induced as well as diet-induced foam cell formation of macrophages in vitro and in vivo, respectively, whereas cholesterol efflux towards HDL of oxLDL-loaded macrophages seems not to be affected by MK2 deficiency. The underlying mechanistic basis of decreased macrophage oxLDL uptake by MK2-deficient macrophages is probably a markedly decreased expression of scavenger receptor A. This mechanism apparently even overrides the impact of the proatherogenic plasma lipoprotein profile observed in hypercholesterolemic MK2-deficient mice.
Interestingly, the phenotype of hypercholesterolemic MK2-deficient mice remarkably resembles the phenotype of hypercholesterolemic SR-A-deficient mice. Similarly to ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice apoE Ϫ/Ϫ /sra Ϫ/Ϫ mice developed Ϸ40% higher plasma cholesterol concentrations compared with hypercholesterolemic control mice. 27, 28 Despite this increased plasma concentrations of proatherogenic lipoproteins, which have been shown to positively correlate with atherosclerotic lesion formation in murine models of atherosclerosis, 29, 30 apoE Ϫ/Ϫ /sra Ϫ/Ϫ mice like ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice did not show a therefore expected increase in atherosclerosis but a decrease or no change in atherosclerosis compared with hypercholesterolemic control mice. 27, 28 Furthermore, SR-A-deficient macrophages accumulated Ϸ50% less cholesterol after exposition to modified LDL-cholesterol in vitro or in vivo compared with control macrophages 27, 28 similarly to the experiments performed in this study employing MK2-deficient peritoneal macrophages. Therefore, the resembling phenotype of MK2-deficient and SR-A-deficient mice/macrophages observed in our experiments and previous studies 27, 28 supports our data indicating a functional role of MK2 for vascular foam cell formation via regulation of SR-A expression.
Recent work has shown that TLR2/4-dependent regulation of SR-A expression is abolished after inhibition of p38-MAPK, 31 the upstream kinase of MK2, suggesting a MK2dependent regulation of SR-A. However, although MK2 is known to regulate the expression of inflammatory mediators (e. g. TNF␣, IL-6) by increasing mRNA stability via targeting AU-rich elements of 3Ј-untranslated regions, 11, 12, 14 expression of SR-A seems not to be primarily regulated by this mechanism as transcript stability was only modestly increased in murine macrophages after increasing mRNAexpression by stimulation with LPS. 32 Therefore, further studies are mandatory to identify the molecular mechanism of MK2-dependent regulation of SR-A expression.
In addition to the reduced vascular deposition of lipids, infiltration of macrophages was strongly reduced (Ϸ70%) in ldlr Ϫ/Ϫ /mk2 Ϫ/Ϫ mice especially in early atherosclerotic lesions, indicating that MK2 regulates processes important for the recruitment of monocytes/macrophages into the diseased vessel wall. Therefore, our study also aimed at identifying potentially underlying processes regulated by MK2 that are crucial for macrophage recruitment into the vessel wall. We demonstrate that MK2 deficiency in hypercholesterolemic ldlr Ϫ/Ϫ mice in vivo and MK2 knockdown in endothelial cells by siRNA in vitro significantly decreased the respective aortic and endothelial cell expression of VCAM-1 and MCP-1, key mediators of macrophage recruitment into the vessel wall. 33, 34 In addition, our data are supported by a recent study demonstrating a reduced pulmonal expression of VCAM-1 and MCP-1 in MK2-deficient mice in an airway inflammation model. 35 As recent studies have shown that MK2 regulates expression of inflammatory mediators (eg, TNF␣, IL-6) by increasing transcript stability via targeting AU-rich elements located in the 3Ј-untranslated region, 11, 12, 14 the presence of AU-rich elements located in the 3Јuntranslated region of the VCAM-1 and MCP-1 coding genes 36 would be consistent with a direct impact of MK2 on VCAM-1 and MCP-1 expression in endothelial cells. Conceivably, reduced recruitment of monocytes/macrophages into the diseased vessel wall would also result in a reduction of the number of macrophages prone to develop into foam cells. This mechanism would be additive to the reduced modified lipid uptake per se observed in this study resulting as a net effect in a significantly decreased vascular deposition of lipids in MK2-deficient mice.
Based on the present results we conclude that MK2 is importantly involved in atherogenesis by promoting the recruitment of inflammatory monocytes/macrophages through increasing endothelial expression of VCAM-1 and MCP-1. In addition, our experiments show that MK2 promotes the formation of foam cells by affecting the uptake of oxLDL via regulating SR-A expression ( Figure 6 ). Importantly, MK2-deficient mice do not develop a lethal phenotype as well as generalized inflammatory disease per se and are even protected against LPS-induced endotoxic shock. 10 In contrast, deficiency of its upstream mediator p38␣/␤-MAPK by genetic disruption causes an embryonically lethal phenotype. 19, 20 Consequently, MK2 seems to be a more selective target for the inhibition of processes important for atherogenesis compared with p38-MAPK and hence the risk for serious side effects after pharmacological inhibition of MK2 in vivo by specific inhibitors to be developed might be low. Therefore, based on our results, MK2 might represent an attractive novel target for the treatment of atherosclerotic cardiovascular disease. 
